Innovations and Emerging Technologies in Pharma Contract Manufacturing
In the dynamic landscape of pharmaceuticals, contract manufacturing plays a pivotal role in ensuring efficiency, quality, and innovation. As the […]
IFC extends $147-million loan to Jubilant Pharma
International Finance Corporation (IFC), a member of the World Bank is lending $147.5 million (around Rs.866 crore) to Jubilant Pharma […]
Parabolic Drugs sales up 54.39 percent in the third quarter
Parabolic Drugs Ltd., a vertically integrated API manufacturer and exporter in India, announced the unaudited results for quarter ended 31st […]
Piramal Group to boost financial business
Piramal Healthcare, which specialises in contract manufacturing and over-the-counter drugs, is looking to raise its research and development spend to […]
BUSINESS
Eli Lilly to expand India opsUS drug major Eli Lilly & Co has decided to expand its business in India […]
DRS Group forays into pharma business, launches DRS Labs
DRS Group, India’s one of leading 3PL player with interests in logistics, supply chain management, warehousing and education will now foray into pharmaceutical business with the launch of its new division, DRS Labs. The division had inaugurated its first of state-of-the-art manufacturing facility at Medchal in Hyderabad.
CRAMS to global pharma companies, give good returns
The pharma sector may have underperformed in the Sensex , but companies providing contract research and manufacturing services (CRAMS) to global pharma companies have given good returns.
CRAMS to global pharma companies, give good returns
The pharma sector may have underperformed in the Sensex , but companies providing contract research and manufacturing services (CRAMS) to global pharma companies have given good returns.
NEWS REVIEW – BUSINESS
[This article was published in the November 2007 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News Review
